# US Nuclear Imaging Devices Market > US Nuclear Imaging Devices Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Applications (Oncology, Cardiology, Neurology, Others) and By Technology (PET, SPECT) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.38% - **2024:** $ 485.1 Million - **2025:** $ 506.35 Million - **2035:** $ 777.52 Million - **Key Players:** Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (IE), Hitachi Medical Corporation (JP), Hologic (US) **Report ID:** MRFR/MED/17928-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-nuclear-imaging-devices-market-19475 --- ## Market Summary ## **US Nuclear Imaging Devices Market Overview** As per MRFR analysis, the US Nuclear Imaging Devices Market Size was estimated at 463.05 (USD Million) in 2023. The US Nuclear Imaging Devices Market Industry is expected to grow from 485.1(USD Million) in 2024 to 1,200 (USD Million) by 2035. The US Nuclear Imaging Devices Market CAGR (growth rate) is expected to be around 8.582% during the forecast period (2025 - 2035). ### **Key US Nuclear Imaging Devices Market Trends Highlighted** In the US Nuclear Imaging Devices Market, there is a significant push towards technological advancements and improved healthcare outcomes. As the demand for early disease detection increases, the adoption of hybrid imaging systems, which combine nuclear imaging with other modalities like CT or MRI, is becoming more prominent. This trend is largely driven by the need for accurate diagnostics and improved treatment planning, particularly for oncology and cardiology cases recognized by healthcare providers. Key market drivers in this domain include an aging population and an increase in chronic diseases that necessitate advanced diagnostic tools. Federal initiatives and funding aimed at improving healthcare infrastructure also bolster the growth of nuclear imaging technologies. The installation of enhanced imaging systems in hospitals and clinics aligns with the US government’s focus on promoting efficient healthcare services. Opportunities to be explored include the expansion of outpatient imaging centers and mobile imaging units, which can make nuclear imaging more accessible to a broader patient population. Furthermore, advancements in software and data analytics are opening new roads for integrating AI and machine learning into nuclear imaging devices, enhancing their capabilities and efficiency in diagnosis. In recent times, regulatory bodies like the FDA are more actively engaged in streamlining the approval process for new technologies, which accelerates the introduction of innovative nuclear imaging solutions. This trend highlights the collaborative efforts between manufacturers and regulatory agencies in the US, aiming to bring safer and more effective imaging devices to the market. Overall, these trends indicate a dynamic and evolving landscape for nuclear imaging in the US, driven by technological innovation, policy support, and a focus on improving patient outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Nuclear Imaging Devices Market Drivers** ### **Increasing Prevalence of Chronic Diseases** The rise in chronic diseases, particularly cardiovascular diseases and cancer, has catalyzed the growth of the US Nuclear Imaging Devices Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 out of 10 adults in the United States have a chronic disease, which supports the demand for advanced imaging technologies. Furthermore, the American Cancer Society has reported that there were an estimated 1.9 million new cancer cases in 2021, indicating a steady increase in cancer diagnoses. This surge necessitates the use of nuclear imaging devices for early diagnosis and treatment planning, thus driving market growth as healthcare providers aim to improve patient outcomes through advanced imaging techniques. ### **Technological Advancements in Imaging Technologies** The advancement in nuclear imaging technology, including the development of more sophisticated Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) systems, is a significant driver for the US Nuclear Imaging Devices Market Industry. According to the Food and Drug Administration (FDA), new approvals for advanced imaging systems have been on the rise, with several innovative products entering the market. Improved image resolution, reduced radiation exposure, and enhanced diagnostic capabilities contribute to this trend, appealing to hospitals and imaging centers seeking to adopt the latest technology to provide superior patient care. ### **Growing Demand for Personalized Medicine** There has been a notable shift towards personalized medicine in the United States, with an increase in tailored treatment plans based on individual patient profiles. This demand is propelling the US Nuclear Imaging Devices Market Industry, as nuclear imaging plays a crucial role in assessing how a patient responds to treatment. The National Institutes of Health (NIH) has indicated that personalized medicine can reduce costs significantly and improve health outcomes, as indicated by a study showing potential savings up to 30% in some cases. This need for specificity in treatment encourages healthcare providers to invest in advanced imaging solutions that facilitate precise medical decisions. ## **US Nuclear Imaging Devices Market Segment Insights** ### **Nuclear Imaging Devices Market End User Insights** The End User segmentation within the US Nuclear Imaging Devices Market plays a crucial role in determining the overall landscape of the industry. Hospitals are among the primary end users of nuclear imaging devices, as they are equipped with advanced medical technologies and trained professionals who utilize these tools for accurate diagnosis and treatment of a variety of conditions, including cancer and cardiovascular diseases. The demand from hospitals is driven by the increasing prevalence of chronic diseases and the need for precise imaging to guide clinical decisions, making them a significant contributor in the adoption of these devices. Then there are Diagnostic Imaging Centers, which offer specialized imaging services that often enhance patient access to nuclear imaging procedures. These centers are usually equipped with advanced imaging technology that allows for a varied range of diagnostic imaging services. As they typically cater to patients referred by other healthcare providers, they play a vital role in the medical ecosystem, facilitating quicker diagnosis and therefore improving patient outcomes. Furthermore, the consolidation of healthcare services often sees these centers partnering with hospitals to expand their service offerings. Additionally, the Others’ category captures various facilities and usages that may include research institutions and outpatient centers. This segment, although relatively smaller, is essential as it contributes to the improvement and development of new imaging technologies through research and clinical trials. The advancement in nuclear imaging devices being pioneered in such environments is vital for the long-term growth and innovation in the industry. The overall trend in the US Nuclear Imaging Devices Market reflects the integration of sophisticated technology in these end-user facilities, with a growing emphasis on capturing real-time data for better diagnostic accuracy. As such, the decision-making processes are increasingly relying on advanced imaging technologies, which amplify the reach and effectiveness of nuclear imaging across clinical settings. Moreover, the healthcare industry's shift towards more outpatient services and integrated care models further reinforces the significance of these segments, leading to a notable expansion within the nuclear imaging niche. Challenges in the sector, such as regulatory hurdles and high initial costs of nuclear imaging devices, are significant but are often balanced by the growing demand for non-invasive procedures and technological advancements that reduce costs over time. Meanwhile, the opportunities appear promising, with increased investments in healthcare infrastructure and the continuous push towards early disease detection spurring future growth in this market subset. Overall, the insights derived from the End User segment offer a comprehensive view of the dynamics at play within the US Nuclear Imaging Devices Market, highlighting areas of growth and improvement that are pivotal for future developments in the healthcare sector. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Nuclear Imaging Devices Market Application Insights** The Application segment of the US Nuclear Imaging Devices Market showcases a diverse range of uses, significantly contributing to the industry's growth. Oncology occupies a prominent position in this segment, driven by the increasing incidence of cancer cases and the demand for precise diagnostic tools. Cardiology follows closely, as the need for advanced imaging techniques to assess cardiac conditions is rising, especially in a country where heart diseases are prevalent. Neurology also plays a critical role in this market, as innovations in imaging technologies enable better diagnosis and management of neurological disorders. The "Others" category encompasses various applications, including research and development, further enhancing the market's breadth. Overall, the integration of emerging technologies and the increasing focus on early diagnosis significantly bolster the US Nuclear Imaging Devices Market revenue, making it a vital component in the healthcare landscape. Market growth is propelled by the aging population and heightened awareness regarding the benefits of nuclear imaging, presenting ample opportunities within these applications to address the evolving healthcare needs. The segmentation highlights the increasing investments in advanced imaging solutions, underlining their importance in improving patient outcomes across various medical disciplines. ### **Nuclear Imaging Devices Market Technology Insights** The US Nuclear Imaging Devices Market, particularly within the Technology segment, is experiencing notable advancements driven by innovations in imaging techniques. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are two prominent technologies that play significant roles in this sector. PET technologies are essential for their high sensitivity and ability to provide functional imaging, which is crucial for cancer detection and monitoring metabolic processes in various diseases. SPECT, on the other hand, is widely recognized for its cost-effectiveness and versatility in cardiac and neurological imaging, dominating the segment due to its availability and sufficient diagnostic capabilities. The growing prevalence of chronic diseases in the US has increased the demand for these imaging technologies, steering market growth. Furthermore, advancements in detector technologies and software enhance image quality and reduce radiation exposure, addressing current healthcare needs. The interplay of these factors positions the Technology segment as a vital element in the evolution of nuclear imaging, contributing to improved patient outcomes and a more efficient healthcare system. As the US continues to focus on advancing healthcare technologies, the integration of PET and SPECT plays a pivotal role in enhancing diagnostic accuracy and treatment efficacy. ## **US Nuclear Imaging Devices Market Key Players and Competitive Insights** The US Nuclear Imaging Devices Market has become increasingly competitive as innovation and technological advancements continue to shape the sector. The market is characterized by a variety of players that are competing to provide advanced diagnostic solutions through nuclear imaging technologies. These companies focus on enhancing their offerings by integrating cutting-edge features that boost the efficiency and accuracy of imaging results. Factors such as rising healthcare expenditure, the prevalence of chronic diseases, and an aging population are driving the demand for nuclear imaging devices. Furthermore, the market is influenced by regulatory approvals, ongoing research activities, and potential collaborations among key industry players. As a result, companies are forging partnerships, expanding their product lines, and enhancing their operational capabilities to strengthen their market position. ### **Hologic** In the context of the US Nuclear Imaging Devices Market, Hologic stands out as a pivotal player due to its strong emphasis on women's health and personalized diagnostic solutions. The company has developed a range of innovative products that cater to various imaging needs, ultimately aiming to improve patient outcomes. Hologic focuses on enhancing the capabilities of their imaging devices to provide high-quality imagery while ensuring effective patient care. Their market presence is amplified by a solid reputation for reliability and the integration of advanced technologies in their offerings. By putting an emphasis on research and development, Hologic continues to strengthen its leadership position, enhancing its product portfolio to meet the evolving needs of healthcare providers and patients in the United States. ### **Nuvectra** Nuvectra has emerged as an important competitor in the US Nuclear Imaging Devices Market, known for its pioneering neural interface technology and solutions. The company’s key products include innovative neurostimulators that target a variety of therapeutic areas, expanding the applications of nuclear imaging in relation to neuromodulation. Nuvectra's market presence is bolstered by its commitment to enhancing the quality of care through groundbreaking technology and effective treatment options. The company's strengths lie in its adaptable product range and focus on clinical evidence, which resonates well with medical practitioners seeking effective solutions for their patients. Recent mergers and acquisitions have allowed Nuvectra to extend its reach and consolidate its technology, enabling the company to innovate continuously. By maintaining a strategic focus on addressing specific healthcare needs in the US, Nuvectra positions itself as a significant contributor to the evolving landscape of nuclear imaging devices. ### **Key Companies in the US Nuclear Imaging Devices Market Include** ## **US Nuclear Imaging Devices Market Industry Developments** The US Nuclear Imaging Devices Market has seen significant developments recently, particularly focusing on advancements in technology and product launches. Companies like Siemens Healthineers and Canon Medical Systems have introduced innovative solutions aimed at enhancing diagnostic imaging capabilities. In May 2023, General Electric announced a collaboration with Hologic to improve imaging accuracy for breast cancer detection, demonstrating the increasing focus on precision medicine. During 2022, Medtronic completed the acquisition of Mazor Robotics, enhancing their imaging technologies, which has had a ripple effect on the market. The valuation of the US Nuclear Imaging Devices Market is projected to grow steadily, attributed to an aging population and the rising prevalence of chronic diseases. As of August 2023, Elekta announced a new product line designed to integrate artificial intelligence in imaging, which is expected to boost efficiency in medical procedures. Meanwhile, Philips Healthcare continues to enhance its portfolio through continuous Research and Development efforts, focusing on combination therapies that leverage nuclear imaging. Over the last two years, companies have been investing heavily in technology that improves patient outcomes, ensuring that the US remains at the forefront of the global nuclear imaging market. ## **US Nuclear Imaging Devices Market Segmentation Insights** ### **Nuclear Imaging Devices Market End User Outlook** ### **Nuclear Imaging Devices Market Application Outlook** ### **Nuclear Imaging Devices Market Technology Outlook** ## Market Drivers ### Rising Awareness of Early Diagnosis The growing awareness of the importance of early diagnosis is a significant driver for the nuclear imaging-devices market. Patients and healthcare professionals alike recognize that early detection of diseases can lead to better treatment outcomes and lower healthcare costs. Campaigns promoting screening and preventive care are becoming more prevalent in the US, encouraging individuals to seek diagnostic imaging services. This heightened awareness is likely to increase the utilization of nuclear imaging devices, as they provide critical information for early disease identification. The nuclear imaging-devices market is expected to expand as more healthcare facilities incorporate these technologies into their diagnostic protocols, ultimately improving patient care and outcomes. ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a primary driver for the nuclear imaging-devices market. As the population ages, the demand for accurate diagnostic tools rises. In the US, chronic diseases account for approximately 70% of all deaths, highlighting the need for advanced imaging technologies. Nuclear imaging devices, which provide detailed insights into physiological processes, are essential for early detection and treatment planning. This trend is likely to propel market growth, as healthcare providers seek innovative solutions to improve patient outcomes. The nuclear imaging-devices market is expected to expand significantly, driven by the necessity for precise diagnostics in managing chronic illnesses. ### Growing Demand for Personalized Medicine The shift towards personalized medicine is reshaping the landscape of the nuclear imaging-devices market. As healthcare moves away from a one-size-fits-all approach, the need for tailored diagnostic solutions becomes paramount. Nuclear imaging devices play a pivotal role in this transition by enabling clinicians to obtain detailed information about individual patient conditions. This trend is supported by the increasing emphasis on precision medicine, which is projected to grow at a CAGR of 11% through 2027. The ability to customize treatment plans based on specific patient profiles enhances the effectiveness of therapies, thereby driving the demand for advanced imaging technologies. Consequently, the nuclear imaging-devices market is poised for growth as healthcare providers adopt these innovative solutions. ### Technological Innovations in Imaging Techniques Technological innovations in imaging techniques are significantly impacting the nuclear imaging-devices market. Advances in detector technology, image processing algorithms, and hybrid imaging systems are enhancing the capabilities of nuclear imaging devices. For instance, the integration of PET/CT and SPECT/CT systems has improved diagnostic accuracy and efficiency. The US market is witnessing a surge in the adoption of these advanced systems, with a projected growth rate of 8% annually. As healthcare providers seek to improve diagnostic outcomes and streamline workflows, the demand for cutting-edge imaging technologies is expected to rise. This trend indicates a robust future for the nuclear imaging-devices market, driven by continuous advancements in imaging methodologies. ### Increased Investment in Healthcare Infrastructure Investment in healthcare infrastructure in the US is a crucial factor influencing the nuclear imaging-devices market. With the ongoing modernization of hospitals and diagnostic centers, there is a growing need for advanced imaging technologies. The US government and private sector are allocating substantial funds to enhance healthcare facilities, which includes upgrading imaging equipment. This investment is projected to reach $200 billion by 2026, fostering an environment conducive to the adoption of nuclear imaging devices. As healthcare providers strive to meet the rising demand for diagnostic services, the nuclear imaging-devices market is likely to benefit from this influx of capital, leading to enhanced technological capabilities and improved patient care. ## Future Outlook The [Nuclear Imaging Devices Market](https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014) is projected to grow at a 4.38% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection. **New opportunities:** - Development of portable imaging devices for remote diagnostics Integration of AI for enhanced image analysis and interpretation Expansion of telemedicine services utilizing nuclear imaging technologies By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing) In the US nuclear imaging-devices market, the application segment is predominantly led by cardiology, which holds the largest share due to the increasing prevalence of cardiovascular diseases and the rising adoption of advanced nuclear imaging techniques. Oncology follows as a significant contributor, driven by the growing incidence of cancer and the demand for precise diagnostic imaging solutions that enhance treatment planning. Growth trends indicate that while cardiology remains a stalwart, oncology is emerging as the fastest-growing segment. Factors such as increasing investments in cancer research, advancements in imaging technology, and a higher emphasis on early diagnosis are propelling oncology's rapid expansion. Additionally, the rising awareness among patients and healthcare providers regarding the benefits of nuclear imaging in cancer detection is further contributing to its growth. Cardiology: Dominant vs. Oncology: Emerging Cardiology is recognized as the dominant segment within the US nuclear imaging-devices market, primarily due to its extensive application in diagnosing heart diseases and [monitoring](../../../reports/fetal-monitoring-market-21968) cardiac health. This segment benefits from established protocols and robust market penetration of imaging technologies like SPECT and PET scans. Conversely, oncology is positioned as an emerging segment, harnessing innovative imaging advancements that facilitate the early detection and targeted treatment of tumors. The demand for personalized medicine and improved imaging accuracy is significantly enhancing oncology's growth trajectory, making it a vital focus area for future developments in nuclear imaging technology. ### By Product Type: Single Photon Emission Computed Tomography (Largest) vs. Positron Emission Tomography (Fastest-Growing) The US nuclear imaging-devices market exhibits a distinct segmentation, with Single Photon Emission Computed Tomography (SPECT) leading in market share due to its widespread application in various diagnostic procedures. This segment captures a significant portion of the overall market, driven by its established use in assessing cardiac and bone diseases. Positron Emission Tomography (PET) follows, offering excellent imaging capabilities but holds a smaller market share despite its advanced technology. Looking ahead, the growth trends indicate a surge in demand for Positron Emission Tomography. This segment is projected to become the fastest-growing due to advancements in technology and an increase in healthcare spending. The rise in prevalence of chronic diseases and the focus on personalized medicine are key drivers for the adoption of PET technology, making it a critical area for future investment and innovation. SPECT (Dominant) vs. PET (Emerging) Single Photon Emission Computed Tomography (SPECT) is recognized as the dominant force in the US nuclear imaging-devices market, due to its cost-effectiveness and versatility in diagnostic applications. SPECT systems are widely utilized in evaluating cardiac conditions, detecting cancers, and exploring neurological disorders, providing essential functional imaging data. In contrast, Positron Emission Tomography (PET) is emerging rapidly, characterized by its ability to deliver exceptional imaging precision and biochemical insights. The integration of PET with CT technology aims to enhance diagnostic accuracy, making it an attractive choice for advanced cancer detection and treatment planning, particularly as healthcare providers move toward more tailored therapeutic strategies. ### By End Use: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing) In the US nuclear imaging-devices market, hospitals hold the largest share among end-users, driven by their comprehensive capability to provide a range of diagnostic services. The centralized nature of hospitals allows them to utilize advanced imaging technologies for diverse patient diagnoses, thereby maintaining a substantial share of market demand. Diagnostic centers emerge as the fastest-growing segment, fueled by an increasing reliance on outpatient services and cost-effective imaging solutions that cater to both patient convenience and reduced healthcare spending. The growth trends within the US nuclear imaging-devices market reflect a shift towards more accessible healthcare services, with both hospitals and diagnostic centers investing in modern imaging technologies. Advancements in technology, coupled with a growing emphasis on early disease detection, are propelling this growth. Research institutions also play a role; however, their market position leans more towards specialized research and development rather than widespread clinical use, making them a smaller but important component of the overall market. Hospitals (Dominant) vs. Diagnostic Centers (Emerging) Hospitals, as the dominant end-use segment in the US nuclear imaging-devices market, leverage extensive facilities and resources to deploy advanced imaging technologies. Their role in comprehensive patient care ensures the sustained demand for nuclear imaging devices. Conversely, diagnostic centers represent an emerging segment, appealing to patients seeking faster and more convenient diagnostic procedures outside of traditional hospital settings. This shift is catalyzed by the desire for cost-effective solutions and shorter wait times, ultimately positioning diagnostic centers as critical players in transforming patient access to imaging services. Both segment values highlight the evolution of healthcare delivery, adjusting to modern patient needs while adopting innovative imaging practices. ### By Technology: Technetium-99m (Largest) vs. Gallium-68 (Fastest-Growing) In the US nuclear imaging-devices market, Technetium-99m holds the largest market share due to its extensive application in various diagnostic procedures. This isotope is predominantly utilized for cardiac imaging, bone scans, and renal function assessments, making it a staple in healthcare facilities across the country. In contrast, Cobalt-60, while significant in some applications, has a smaller market presence as compared to Technetium-99m and Gallium-68. Gallium-68, used primarily in tumor imaging, is increasingly being recognized for its effectiveness, contributing to its rising market share. The growth trends in the segment reveal that Technetium-99m will likely maintain its dominance, but the pace at which Gallium-68 is growing suggests an emerging preference among clinicians for targeted imaging techniques. The drivers for this growth include advancements in radiopharmaceuticals and increasing awareness of precision medicine. The ongoing research and development in the field of nuclear imaging also play a vital role in enhancing the market dynamics, enabling better technology adoption and innovation within the market. Technology: Technetium-99m (Dominant) vs. Gallium-68 (Emerging) Technetium-99m, often referred to as the backbone of nuclear medicine, is characterized by its favorable physical properties, including a short half-life and ideal emission characteristics for imaging. Its established use in various diagnostic procedures makes it a trusted choice for healthcare providers. On the other hand, Gallium-68 is emerging as a significant player in the market, especially for specific types of cancer diagnosis due to its efficiency in positron emission tomography (PET) imaging. The increasing preference for Gallium-68 can be attributed to its capability to deliver more precise imaging results and reduced patient radiation exposure, positioning it as a prominent alternative in the evolving landscape of nuclear imaging. ## Competitive Benchmarking The nuclear imaging-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic tools. Major players such as Siemens Healthineers (Germany), GE Healthcare (GB), and Philips Healthcare (Netherlands) are at the forefront, each adopting distinct strategies to enhance their market presence. Siemens Healthineers (Germany) emphasizes innovation through the development of advanced imaging technologies, while GE Healthcare (GB) focuses on strategic partnerships to expand its product offerings. Philips Healthcare (Netherlands) is investing heavily in digital transformation, aiming to integrate AI into its imaging solutions, thereby enhancing diagnostic accuracy and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological differentiation and customer-centric solutions. Key business tactics within the nuclear imaging-devices market include localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The market structure appears moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a variety of innovative solutions to emerge, as companies strive to capture market share through unique offerings and tailored services. The collective influence of these major players shapes the competitive dynamics, fostering an environment where innovation is paramount. In October 2025, Siemens Healthineers (Germany) announced the launch of its latest PET/CT scanner, which integrates AI capabilities to improve image quality and reduce scan times. This strategic move is likely to enhance Siemens' competitive edge by addressing the growing demand for faster and more accurate diagnostic tools, thereby positioning the company as a leader in advanced imaging technology. The integration of AI not only streamlines operations but also aligns with the broader trend of digitalization in healthcare. In September 2025, GE Healthcare (GB) entered a strategic partnership with a leading telehealth provider to enhance remote diagnostic capabilities. This collaboration is indicative of GE's commitment to expanding its service offerings and adapting to the evolving healthcare landscape. By integrating telehealth solutions with its imaging devices, GE Healthcare (GB) aims to provide comprehensive care that meets the needs of patients and healthcare providers alike, potentially increasing its market share in the rapidly growing telehealth sector. In August 2025, Philips Healthcare (Netherlands) unveiled a new line of imaging devices designed with sustainability in mind, utilizing eco-friendly materials and energy-efficient technologies. This initiative not only reflects Philips' commitment to environmental responsibility but also positions the company favorably among increasingly eco-conscious consumers and healthcare institutions. The focus on sustainability may enhance Philips' brand reputation and attract new customers who prioritize environmentally friendly solutions. As of November 2025, current competitive trends in the nuclear imaging-devices market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming increasingly important, as companies seek to leverage complementary strengths to enhance their offerings. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, advanced technology, and supply chain reliability. This transition underscores the necessity for companies to continuously adapt and innovate in order to maintain a competitive advantage in a rapidly changing market. ## Recent News & Developments The US Nuclear Imaging Devices Market has seen significant developments recently, particularly focusing on advancements in technology and product launches. Companies like Siemens Healthineers and Canon Medical Systems have introduced innovative solutions aimed at enhancing diagnostic imaging capabilities. In May 2023, General Electric announced a collaboration with Hologic to improve imaging accuracy for breast cancer detection, demonstrating the increasing focus on precision medicine. During 2022, Medtronic completed the acquisition of Mazor Robotics, enhancing their imaging technologies, which has had a ripple effect on the market. The valuation of the US Nuclear Imaging Devices Market is projected to grow steadily, attributed to an aging population and the rising prevalence of chronic diseases. As of August 2023, Elekta announced a new product line designed to integrate artificial intelligence in imaging, which is expected to boost efficiency in medical procedures. Meanwhile, Philips Healthcare continues to enhance its portfolio through continuous Research and Development efforts, focusing on combination therapies that leverage nuclear imaging. Over the last two years, companies have been investing heavily in technology that improves patient outcomes, ensuring that the US remains at the forefront of the global nuclear imaging market. ## Report Scope | MARKET SIZE 2024 | 485.1(USD Million) | | --- | --- | | MARKET SIZE 2025 | 506.35(USD Million) | | MARKET SIZE 2035 | 777.52(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.38% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (IE), Hitachi Medical Corporation (JP), Hologic (US) | | Segments Covered | Application, Product Type, End Use, Technology | | Key Market Opportunities | Advancements in hybrid imaging technologies enhance diagnostic accuracy in the nuclear imaging-devices market. | | Key Market Dynamics | Technological advancements drive innovation in nuclear imaging devices, enhancing diagnostic capabilities and market competitiveness. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US nuclear imaging-devices market in 2024?** A: The overall market valuation was $485.1 Million in 2024. **Q: What is the projected market valuation for the US nuclear imaging-devices market by 2035?** A: The projected valuation for 2035 is $777.52 Million. **Q: What is the expected CAGR for the US nuclear imaging-devices market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 4.38%. **Q: Which application segment had the highest valuation in 2024?** A: The oncology application segment had the highest valuation, ranging from $150.0 Million to $250.0 Million. **Q: What are the projected valuations for the cardiology application segment by 2035?** A: The cardiology application segment is projected to range from $80.0 Million to $130.0 Million by 2035. **Q: Which product type is expected to show the highest growth in the US nuclear imaging-devices market?** A: The positron emission tomography product type is expected to show the highest growth, with valuations projected between $180.0 Million and $290.0 Million. **Q: What is the valuation range for hospitals as an end-use segment in 2024?** A: The valuation range for hospitals as an end-use segment was between $200.0 Million and $320.0 Million in 2024. **Q: Which technology segment had the highest valuation in 2024?** A: The technetium-99m technology segment had the highest valuation, ranging from $250.0 Million to $400.0 Million. **Q: Who are the key players in the US nuclear imaging-devices market?** A: Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and others. **Q: What is the projected valuation for the hybrid imaging systems product type by 2035?** A: The projected valuation for hybrid imaging systems is expected to range from $155.1 Million to $247.52 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-nuclear-imaging-devices-market-19475*